In line with this study, Majdi [106] and colleagues showed that the inhibition of RIPK1 improved NASH characteristics in HFD-fed mice and reversed steatosis through an MLKL-dependent mechanism that mainly affects mitochondrial respiration. The gene discussed is MLKL; the disease is metabolic dysfunction-associated steatohepatitis.